Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer (REST)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01334983|
Recruitment Status : Completed
First Posted : April 13, 2011
Last Update Posted : April 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Cancer||Behavioral: REST||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||68 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Phase II Randomized Controlled Trial of Rapid and Easy Strength Training to Preserve Function in Late Stage Cancer|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||November 2010|
|Actual Study Completion Date :||November 2010|
Participants instructed in individualized Rapid Easy Strength Training and pedometer-based walking programs
Instruction in an individualized rapid easy strength training (isotonic with therabands) and pedometer-based walking programs.
No Intervention: Wait list control
Participants instructed in REST after completing week 8 outcome measures
- Ambulatory Post Acute Care Basic Mobility Short Form [ Time Frame: 8 weeks ]Patient reported outcome with 18 items assessed functionality in basic mobility. Response option for all items is a 4 level Likert scale
- Ambulatory Post Acute Care Short Form Daily Activities [ Time Frame: 8 weeks ]Patient reported outcome with 15 items assessing functionality with respect to the performance of activities of daily living.
- Linear Analoge Self Assessment of Quality of Life [ Time Frame: 8 weeks ]7 item patient reported outcome assessing over-all quality of life and quality of life domains, e.g. mental, social, etc.
- FACIT-F [ Time Frame: 8 weeks ]Patient reported outcome assessing overall quality of life among patients with cancer and fatigue
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01334983
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|